Can-Fite’s Former Subsidiary OphthaliX Successfully Completes Merger with Wize Pharma
Can-Fite BioPharma Ltd. | November 17, 2017
Can-Fite BioPharma Ltd, a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver, and inflammatory diseases, today announced that its previously majority-owned subsidiary OphthaliX, Inc.